- Report
- October 2023
- 80 Pages
South Korea
From €1345EUR$1,500USD£1,153GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1345EUR$1,500USD£1,153GBP
- Report
- October 2023
- 80 Pages
India
From €1345EUR$1,500USD£1,153GBP
- Report
- October 2023
- 80 Pages
Germany
From €1345EUR$1,500USD£1,153GBP
- Report
- October 2023
- 80 Pages
France
From €1345EUR$1,500USD£1,153GBP
- Report
- October 2023
- 80 Pages
China
From €1345EUR$1,500USD£1,153GBP
- Report
- October 2023
- 350 Pages
Global
From €1121EUR$1,250USD£961GBP
€2242EUR$2,500USD£1,922GBP
- Report
- June 2023
- 182 Pages
Global
From €3228EUR$3,600USD£2,768GBP
- Report
- June 2023
- 76 Pages
North America
From €1345EUR$1,500USD£1,153GBP
- Report
- April 2025
- 88 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- July 2025
- 94 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- April 2025
- 135 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- June 2025
- 135 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- July 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- July 2025
- 155 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- July 2025
- 170 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- June 2025
- 92 Pages
Europe
From €3542EUR$3,950USD£3,037GBP
- Report
- June 2025
- 101 Pages
Global
From €3094EUR$3,450USD£2,653GBP
- Report
- June 2025
- 128 Pages
Canada
From €5376EUR$5,995USD£4,610GBP
- Report
- June 2025
- 126 Pages
Australia
From €5376EUR$5,995USD£4,610GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more